Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent expirations
Pharma
Teva hit with €463M fine over Copaxone misconduct claims in EU
The European Commission fined Teva 462.6 million euros over claims that it “[abused] its dominant market position to delay competition” to Copaxone.
Fraiser Kansteiner
Oct 31, 2024 10:45am
'The Top Line': 2023's exclusivity losses, this week's news
Apr 7, 2023 7:30am
The top 10 drug patent expirations of 2023
Mar 13, 2023 3:00am
The top 20 drugs by 2021 sales
May 31, 2022 3:00am
BMS, Amgen and Pfizer face steepest patent cliffs
Dec 29, 2021 9:56am
Senate, FDA urge USPTO to alter drug patent application process
Sep 14, 2021 9:15am
